… Mucositis is a highly significant, and sometimes dose-limiting, toxicity of cancer therapy. The
… the Multinational Association of Supportive Care in Cancer and International Society of Oral …

Background Mucositis is a significant toxicity of cancer therapy with numerous systemic
sequelae. The goal of this systematic review was to update the Multinational Association of …

… mucositis is a common adverse effect of anticancer therapy and can contribute negatively to
patient outcomes. The optimal management … the pathophysiology of mucositis should inform …

… mucositis, debating the impact of standard chemo-radiotherapy and targeted therapy on
mucositis development and pointing out the limits and the benefits of current mucositis treatment …

… There have been literally hundreds of clinical trials to evaluate different modalities to
manage or prevent cancer therapy-induced oral mucositis. The data from these trials is often …

… management Oropharyngeal pain can be the most significant patient complaint during cancer
therapy, commonly occurring because of mucositis, and … Symptom management requires …

… of mucositis. Considering that both cancer therapy and therapeutic agents for mucositis
act on both normal and cancer cells, agents that inhibit mucositis should act through …

… Oral Mucositis (OM) is among the most common and dreaded toxicities of cancer therapy. It
… for lesions specifically associated with cytotoxic cancer therapy, and in 2007 was adopted …

… Mucositis is one of the most common and debilitating toxicities of all forms of cytotoxic
cancer therapy. The diffuse ulcerations that develop cause extreme discomfort, interfere with …

… The purpose of basic oral care is to maintain the patient's baseline oral health and reduce
the impact of cancer therapy on the oral mucosa. Good oral hygiene practices are thought to …